{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-056188","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2025-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.629787+00:00","generated_at":"2026-05-19T01:39:13.079931+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Unicycive Therapeutics effects 1-for-10 reverse stock split to regain Nasdaq compliance","bullets":["Reverse stock split at 1-for-10 ratio effective June 18, 2025; begins trading split-adjusted June 20, 2025.","Reduces outstanding shares from ~126.4M to ~12.6M; no fractional shares (rounded up).","CUSIP changes to 90466Y 202; symbol remains UNCY.","Board authorized reverse split on June 9, 2025; split intended to meet $1.00 minimum bid price for Nasdaq listing.","Proportional adjustments to stock options, warrants, and preferred stock conversion prices."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-056188","json":"https://secwatch.observer/filing/0001213900-25-056188.json","markdown":"https://secwatch.observer/filing/0001213900-25-056188.md","text":"https://secwatch.observer/filing/0001213900-25-056188.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025056188/0001213900-25-056188-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025056188/ea0246299-8k_unicycive.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T01:39:13.079931+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5356c02e17256bfef9ece06b59ea063105322ee4","claim":"Unicycive Therapeutics, Inc.: Filed a Certificate of Amendment to effect a 1-for-10 reverse stock split of Common Stock (effective 2025-06-18).","evidence_excerpt":"On June 18, 2025, the Company filed the Charter Amendment with the Secretary of State of the State of Delaware to effectuate the Reverse Stock Split.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025056188/0001213900-25-056188-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-18"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}